Medical professionals should take into account no matter if their clients with underlying NAION threat elements can be adversely influenced by utilization of PDE5 inhibitors. Individuals who have by now skilled NAION are at enhanced threat of NAION recurrence. As a result, PDE5 inhibitors, together with LEVITRA, need to be used with warning in thes